Maurice P.H.M. Jansen

3.1k citations

66 papers · 2.2k indexed · h-index 26

Molecular Biology top 5%
Cancer Research top 1%
Oncology top 5%
Pulmonary and Respiratory Medicine top 10%
Genetics top 5%

Co-authors: Els M.J.J. Berns John A. Foekens Maxime P. Look Stefan Sleijfer Iris L. van Staveren Marion E. Meijer‐van Gelder Anieta M. Sieuwerts Jozien Helleman
Topics: Cancer Genomics and Diagnostics (33 papers)Estrogen and related hormone effects (13 papers)Genetic factors in colorectal cancer (12 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Journal of Clinical Oncology Cancer Research Oncogene
Partner nations: Netherlands Italy Belgium

In The Last Decade

Maurice P.H.M. Jansen

62 papers receiving 2.2k citations

Peers

Countries citing papers authored by Maurice P.H.M. Jansen

Since Specialization

Citations

This map shows the geographic impact of Maurice P.H.M. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice P.H.M. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice P.H.M. Jansen more than expected).

Fields of papers citing papers by Maurice P.H.M. Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice P.H.M. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice P.H.M. Jansen. The network helps show where Maurice P.H.M. Jansen may publish in the future.

Co-authorship network of co-authors of Maurice P.H.M. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice P.H.M. Jansen. A scholar is included among the top collaborators of Maurice P.H.M. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice P.H.M. Jansen. Maurice P.H.M. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genome-wide cell-free DNA methylation profiling in advanced stage ovarian cancer. Are we looking at the tumor or the patient's immune response to the tumor? 2025 ·Cancer Treatment and Research Communications ·(unknown),(unknown),Ingrid Boere,Ruben Boers,Joachim Boers,Wilfred F. J. van IJcken,Maurice P.H.M. Jansen,(unknown),Joost Gribnau,Heleen J. van Beekhuizen	0
2	Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer 2024 ·Cell Death and Differentiation ·Tong Xu,(unknown),Miriam Teeuwssen,Wenjie Sun,Rosalie Joosten,Andrea Sacchetti,Patricia C. Ewing‐Graham,Maurice P.H.M. Jansen,Ingrid Boere,Nicole S. Bryce,Jun Zeng,Herbert Treutlein,Jeff Hook,Edna C. Hardeman,Peter W. Gunning,Riccardo Fodde	5
3	Circulating tumor cells and tumor DNA in patients with resectable colorectal liver metastases: The MIRACLE. 2024 ·Journal of Clinical Oncology ·(unknown),Maurice P.H.M. Jansen,Jaco Kraan,Corine M. Beaufort,(unknown),Eric J.T. Belt,Maarten Vermaas,Paul D. Gobardhan,Stefan Sleijfer,Henk M.W. Verheul,Saskia M. Wilting,Dirk J. Grünhagen,John W.M. Martens,Cornelis Verhoef	1
4	Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients 2024 ·Genes ·(unknown),(unknown),Ruben Boers,Jean Helmijr,(unknown),(unknown),(unknown),Corine M. Beaufort,Jaco Kraan,Wilfred F. J. van IJcken,Joost Gribnau,(unknown),(unknown),(unknown),Heleen J. van Beekhuizen,Tuba Günel,Saskia M. Wilting,John W.M. Martens,Maurice P.H.M. Jansen,Ingrid Boere	4
5	External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium 2024 ·Clinical Chemistry ·Paul van der Leest,(unknown),John W. J. Hinrichs,Carel J.M. van Noesel,Karen Zwaenepoel,Birgit Deiman,(unknown),Ronald van Eijk,Ernst‐Jan M. Speel,(unknown),Marjolijn J. L. Ligtenberg,(unknown),Maurice P.H.M. Jansen,Hendrikus J. Dubbink,(unknown),Mathie P.G. Leers,Menno Tamminga,Daan van den Broek,Léon C.L.T. van Kempen,Ed Schuuring	1
6	Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels 2023 ·Scientific Reports ·Elisabeth M. Jongbloed,Maurice P.H.M. Jansen,Vanja de Weerd,(unknown),Corine M. Beaufort,Marcel Reinders,Ronald van Marion,Wilfred F. J. van IJcken,Gabe S. Sonke,Inge R. Konings,Agnes Jager,John W.M. Martens,Saskia M. Wilting,(unknown)	2
7	Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer 2022 ·The Journal of Pathology ·Ben M. Eyck,Maurice P.H.M. Jansen,Bo Jan Noordman,Peggy N. Atmodimedjo,Berend J. van der Wilk,John W.M. Martens,(unknown),Corine M. Beaufort,Bianca Mostert,Michail Doukas,Bas P. L. Wijnhoven,Sjoerd M. Lagarde,J. Jan B. van Lanschot,Winand N.M. Dinjens	9
8	The COMPLETE trial: HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study 2022 ·BMJ Open ·Gerda M. Verduijn,(unknown),(unknown),(unknown),Juan A. Hernández‐Tamames,Wilma D. Heemsbergen,Aniel Sewnaik,José A. Hardillo,Hetty Mast,Yvette van Norden,Maurice P.H.M. Jansen,Aad van der Lugt,Dik C. van Gent,Mischa S. Hoogeman,Bianca Mostert,Steven Petit	1
9	Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling 2022 ·Clinical Chemistry ·Paul van der Leest,(unknown),Carel J.M. van Noesel,Daan van den Broek,(unknown),Birgit Deiman,(unknown),Robert van der Geize,(unknown),Ernst‐Jan M. Speel,Maartje J. Geerlings,(unknown),Maurice P.H.M. Jansen,(unknown),Else Driehuis,Mathie P.G. Leers,Grigory Sidorenkov,Menno Tamminga,Léon C.L.T. van Kempen,Ed Schuuring	18
10	High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms 2018 ·Molecular Oncology ·Lisanne F. van Dessel,Silvia Rita Vitale,Jean Helmijr,Saskia M. Wilting,Michelle van der Vlugt‐Daane,Esther Oomen‐de Hoop,Stefan Sleijfer,John W.M. Martens,Maurice P.H.M. Jansen,Martijn P. Lolkema	38
11	SNPitty 2018 ·Journal of Molecular Diagnostics ·Job van Riet,(unknown),Peggy N. Atmodimedjo,Erwin Brosens,Wilfred F. J. van IJcken,Maurice P.H.M. Jansen,John W.M. Martens,Leendert H. J. Looijenga,Guido Jenster,Hendrikus J. Dubbink,Winand N.M. Dinjens,Harmen J.G. van de Werken	13
12	Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA 2017 ·Scientific Reports ·Marjolein J.A. Weerts,Ronald van Marion,Jean Helmijr,Corine M. Beaufort,(unknown),Anita Trapman-Jansen,Winand N.M. Dinjens,Stefan Sleijfer,Maurice P.H.M. Jansen,John W.M. Martens	6
13	Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis 2017 ·Translational Oncology ·(unknown),Anne Timmermans,(unknown),John W.M. Martens,Els M.J.J. Berns,Maurice P.H.M. Jansen	5
14	LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome 2016 ·Molecular Oncology ·(unknown),Kirsten Ruigrok-Ritstier,Jean Helmijr,Maxime P. Look,(unknown),Luc Dirix,Els M.J.J. Berns,Maurice P.H.M. Jansen	29
15	Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases 2016 ·Molecular Oncology ·Nick Beije,Jean Helmijr,Marjolein J.A. Weerts,Corine M. Beaufort,Matthew Wiggin,Andre Marziali,Cornelis Verhoef,Stefan Sleijfer,Maurice P.H.M. Jansen,John W.M. Martens	63
16	High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer 2014 ·Annals of Oncology ·(unknown),A. Mieke Timmermans,Maxime P. Look,Marion E. Meijer‐van Gelder,(unknown),Carolien H. M. van Deurzen,John W.M. Martens,Stefan Sleijfer,John A. Foekens,P.M.J.J. Berns,Maurice P.H.M. Jansen	46
17	Hallmarks of Aromatase Inhibitor Drug Resistance Revealed by Epigenetic Profiling in Breast Cancer 2013 ·Cancer Research ·Maurice P.H.M. Jansen,Theo Knijnenburg,(unknown),Iris Simón,Ron Kerkhoven,Marjolein Droog,Arno Velds,Steven Van Laere,Luc Dirix,Xanthippi Alexi,John A. Foekens,Lodewyk F.A. Wessels,Sabine C. Linn,Els M.J.J. Berns,Wilbert Zwart	57
18	Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen 2013 ·Breast Cancer Research and Treatment ·(unknown),Jean Helmijr,Maxime P. Look,Irene Lurkin,Kirsten Ruigrok-Ritstier,Steven Van Laere,Luc Dirix,Fred C.G.J. Sweep,Paul N. Span,Sabine C. Linn,John A. Foekens,Stefan Sleijfer,Els M.J.J. Berns,Maurice P.H.M. Jansen	43
19	Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response 2008 ·Clinical Cancer Research ·Jozien Helleman,Maurice P.H.M. Jansen,Kirsten Ruigrok-Ritstier,Iris L. van Staveren,Maxime P. Look,Marion E. Meijer‐van Gelder,Anieta M. Sieuwerts,Jan G.M. Klijn,Stefan Sleijfer,John A. Foekens,Els M.J.J. Berns	142
20	Serum proteomic patterns for ovarian cancer monitoring 2007 ·International Journal of Gynecological Cancer ·Jozien Helleman,(unknown),Maurice P.H.M. Jansen,Theo M. Luider,M.E.L. van der Burg,G. Stoter,E. Berns	19

About Maurice P.H.M. Jansen

Maurice P.H.M. Jansen is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 66 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (33 papers), Estrogen and related hormone effects (13 papers) and Genetic factors in colorectal cancer (12 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (806 citations) and Molecular Biology (1.3k citations). Maurice P.H.M. Jansen has collaborated with scholars based in Netherlands, Italy and Belgium. Frequent co-authors include Els M.J.J. Berns, John A. Foekens, Maxime P. Look, Stefan Sleijfer, Iris L. van Staveren, Marion E. Meijer‐van Gelder, Anieta M. Sieuwerts, Jozien Helleman, Jan G.M. Klijn and John W.M. Martens. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact